Recovery of HBV-specific B cell function after discontinuation of nucleos(t)ide analogue therapy: new insight and future challenges

Related Experiment Video

Updated: Jan 7, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.3K

Antonio Bertoletti1, Shubhankar Sunil Ambike2

  • 1Duke-NUS Medical School, Singapore antonio@duke-nus.edu.sg.

Gut
|January 2, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CHRONIC VIRAL HEPATITIS

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.4K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.2K

Related Experiment Videos

Last Updated: Jan 7, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.3K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.4K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.2K

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K

Articles linked to this work by shared authors, journal, and citation graph.

Sex-specific trajectories of nonlinear immune aging at single-cell level.

Nature communications·2026

DC subsets and states unraveled across human juxtatumoral and malignant tissues.

Nature immunology·2025

Decoding HBV-specific adaptive immunity: from natural clearance to cure.

Gut·2025

CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming.

Nature immunology·2025

Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans.

Nature microbiology·2025

A rapid method to assess the in vivo multi-functionality of adoptively transferred engineered TCR T cells.

Immunotherapy advances·2024

Short-term risk prediction model for pancreatic cancer in type 2 diabetes: development and validation across two independent Chinese cohorts.

Gut·2026

Phosphate-modified PROTECs as potent antivirals against respiratory syncytial virus by targeting the fusion protein.

Journal of materials chemistry. B·2026

Artificial Intelligence-Assisted Automated Optical Coherence Tomography Analysis for Percutaneous Coronary Intervention Planning: From Plaque Analysis to Precision Lesion Preparation and Stent Optimization.

Journal of the American Heart Association·2026

The NEO-1 gene may serve as a potential biomarker for predicting acute myocardial infarction.

Open medicine (Warsaw, Poland)·2026

Nanoimaging, Spectroscopy, and Biosensor Assays for Alternatively Spliced RNA Isoforms in Disease Diagnostics.

ACS omega·2026

Virology-aware artificial intelligence for respiratory antiviral discovery: from molecular docking biases to RdRp-centered benchmarking.

Frontiers in pharmacology·2026

Implementation of the National Asthma Guidelines in New Zealand: a retrospective patient-level study of the change to anti-inflammatory reliever therapy in 324,972 patients.

The Lancet regional health. Western Pacific·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us